Volume 4 Supplement 2

Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research

Open Access

Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States

  • M Guech-Ongey1,
  • EA Engels1,
  • JJ Goedert1,
  • RJ Biggar1, 2 and
  • SM Mbulaiteye1
Infectious Agents and Cancer20094(Suppl 2):P21

https://doi.org/10.1186/1750-9378-4-S2-P21

Published: 17 June 2009

Squamous cell carcinoma of the conjunctiva (SCCC) has been associated with HIV infection in equatorial Africa, but the evidence for association with HIV in developed countries, where SCCC is rarer, is controversial. We investigated the risk for SCCC and other eye cancers in the updated U.S. HIV/AIDS Cancer Match Registry Study. We calculated standardized incidence ratios (SIRs) to estimate excess risk for SCCC, primary ocular lymphoma, ocular Kaposi sarcoma (KS), and other eye tumors among 491, 048 adults (age > 15 years or older) with HIV/AIDS diagnosed from 1980 to 2004. We calculated relative proportions (per 105) to gain insight into risk factors. We identified 73 eye cancers (15 SCCC, 35 primary ocular lymphoma, 17 ocular KS, and 6 other). Overall SIRs were elevated for SCCC (SIR, 12.2, 95% CI 6.8 – 20.2), primary ocular lymphoma (21.7, 95% CI 15.1–30.2), and ocular KS (109, 95% CI 63.5–175). Risk for SCCC was elevated regardless of HIV acquisition category, CD4 lymphocyte count, and time-relative to AIDS-onset. Relative proportions of SCCC risk were highest with age ≥50 (8/105), Hispanic ethnicity (7/105), and residence in regions with high solar ultraviolet radiation (10/105). We show significantly increased incidence of SCCC among persons with HIV/AIDS in the United States. The associations with age and geography are in accord with etiological role for ultraviolet radiation in SCCC.

Authors’ Affiliations

(1)
Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute
(2)
Department of Epidemiology Research, State Serum Institute

Copyright

© Guech-Ongey et al; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd.

Advertisement